[Action mechanism of drugs on connective tissue metabolism]. 1977

T Horiuchi, and E Ishikawa

UI MeSH Term Description Entries
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003238 Connective Tissue Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX. Connective Tissues,Tissue, Connective,Tissues, Connective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000500 Allylestrenol A synthetic steroid with progestational activity. Allyloestrenol,Gestanin,Gestanon,Turinal
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

T Horiuchi, and E Ishikawa
February 1972, The Journal of laboratory and clinical medicine,
T Horiuchi, and E Ishikawa
January 1971, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
T Horiuchi, and E Ishikawa
January 1963, Experimental medicine and surgery,
T Horiuchi, and E Ishikawa
October 1975, Minerva medica,
T Horiuchi, and E Ishikawa
November 1956, Annals of the New York Academy of Sciences,
T Horiuchi, and E Ishikawa
January 1961, Comptes rendus des seances de la Societe de biologie et de ses filiales,
T Horiuchi, and E Ishikawa
September 1961, Medicamenta,
T Horiuchi, and E Ishikawa
January 1959, Annual review of biochemistry,
T Horiuchi, and E Ishikawa
April 1963, Acta medicinae Okayama,
T Horiuchi, and E Ishikawa
March 1973, Metabolism: clinical and experimental,
Copied contents to your clipboard!